We've Got What You've Been Looking For
Comprehensive Perimenopause & Menopause Toolkit for Symptom Relief and Support
Menopause in the News
Stay Informed on the Latest Menopause Research, Therapies, and Women’s Health Developments
UK Approves First Testosterone Cream for Women, Marking a Historic Shift in Menopause Care
In the UK, a testosterone cream formulated specifically for women was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in August 2025. Before this, testosterone was not licensed for women, and male-strength gels were prescribed "off-label" in lower doses, as is currently the case in the US and elsewhere.
FDA Panel Reconsiders Black Box Warning on Low-Dose Vaginal Estrogen
An FDA-convened panel of medical experts heard testimony in July 2025 supporting the removal of the black box warning from low-dose vaginal estrogen therapies. Experts argued that the warning, which dates to 2003, is inaccurate and scares women away from a safe and effective treatment for menopausal symptoms.
New Research Finds Early Menopause Hormone Therapy May Offer Big Benefits with Lower Risks
This new perspective contrasts with the widespread alarm caused by the initial 2002 Women's Health Initiative (WHI) trial findings, which suggested serious risks and led many women and doctors to avoid hormone therapy (HT). Current research clarifies that those risks were primarily associated with older participants who began therapy many years after menopause using older, higher-dose formulations.
New Non-Hormonal Treatment Offers Relief from Menopausal Hot Flashes — With Safety Caveats
The U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. Veozah is the first neurokinin 3 (NK3) receptor antagonist approved by the FDA to treat moderate to severe hot flashes from menopause. It works by binding to and blocking the activities of the NK3 receptor, which plays a role in the brain’s regulation of body temperature.
The End of Menopause? Scientists Explore Radical New Possibilities
Could menopause one day be optional? Scientists are exploring radical new ways to delay or even prevent it, from ovarian tissue freezing to groundbreaking hormonal research.
Could a Weekly Pill Delay Menopause? Rapamycin Research Shows Promise
Early clinical research indicates that a weekly rapamycin pill could delay menopause by slowing the aging of the ovaries. A pilot study conducted at Columbia University showed promising results, and a larger trial is now underway. While the findings are encouraging, this treatment is still experimental, and its long-term safety and efficacy need further confirmation.
Elinzanetant Under FDA Review: A Potential New Non-Hormonal Option for Menopausal Symptoms
Elinzanetant (Lynkuet) is a new non-hormonal therapy under FDA review that could finally provide relief from hot flashes for women who can’t or prefer not to take hormone therapy. Promising trial results offer hope for midlife symptom relief.
Menopause Symptom Insights
Our Latest Articles on Perimenopause & Menopause Issues
The drop in estrogen during menopause significantly increases the risk of osteoporosis and fractures, making bone density testing cruci...
Millions of women suffer for years with unexplained symptoms like anxiety, brain fog, joint pain, and sleep problems before anyone reco...
Tingling toes? Sudden zaps of electricity? That’s not your imagination—it’s menopause. Let’s decode the nerve symptoms no one talks abo...